Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial

• Main Authors: Jose Lenin Beltran Gonzalez (Author), Mario González Gámez (Author), Emanuel Antonio Mendoza Enciso (Author), Ramiro Josue Esparza Maldonado (Author), Daniel Hernández Palacios (Author), Samuel Dueñas Campos (Author), Itzel Ovalle Robles (Author), Mariana Jocelyn Macías Guzmán (Author), Andrea Lucia García Díaz (Author), César Mauricio Gutiérrez Peña (Author), Lucila Martinez Medina (Author), Victor Antonio Monroy Colin (Author), Jose Manuel Arreola Guerra (Author)
• Format: Book
• Published: MDPI AG, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

During the first year of the COVID-19 pandemic, unauthorized drugs were widely used. Ivermectin and hydroxychloroquine are drugs that inhibit viral replication in vitro and that have been used in several medical centers. This clinical trial analyzes their efficacy in hospitalized patients with moder...